S&P 500
(2.11%) 5 086.88 points
Dow J
(1.17%) 39 063 points
Nasdaq
(2.96%) 16 041 points
Oil
(0.73%) $78.48
Gas
(-2.59%) $1.727
Gold
(-0.05%) $2 033.30
Silver
(-0.42%) $22.78
Platinum
(1.95%) 906.95
USD/EUR
(0.02%) 0.924
USD/NOK
(0.44%) 10.51
USD/GBP
(-0.16%) 0.790
USD/RUB
(1.15%) 93.04

Realtime updates for Aeterna Zentaris Inc [AEZS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated22 Feb 2024 @ 14:45

-2.57% $ 1.734

Live Chart Being Loaded With Signals

Commentary (22 Feb 2024 @ 14:45):
Profile picture for Aeterna Zentaris Inc

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications...

Stats
Today's Volume 12 154.00
Average Volume 14 275.00
Market Cap 8.42M
EPS $-0.850 ( 2023-11-09 )
Next earnings date ( $-0.970 ) 2024-03-28
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.360
ATR14 $0.0210 (1.21%)

Aeterna Zentaris Inc Correlation

10 Most Positive Correlations
FDMT0.971
FTXG0.968
KIDS0.964
CTKB0.964
ACCD0.962
SANA0.961
UAL0.961
STKS0.961
VIAV0.96
FMHI0.959
10 Most Negative Correlations
MTRX-0.957
XLRN-0.944
ATRS-0.942
GXII-0.939
KSICU-0.939
EACPU-0.938
HERA-0.938
MURFU-0.937
HNRG-0.936
ZING-0.936

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aeterna Zentaris Inc Financials

Annual 2022
Revenue: $5.64M
Gross Profit: $5.48M (97.22 %)
EPS: $-7.76
Q3 2023
Revenue: $3 000.00
Gross Profit: $-8 000.00 (-266.67 %)
EPS: $-0.850
Q2 2023
Revenue: $2.25M
Gross Profit: $2.11M (93.81 %)
EPS: $-0.520
Q1 2023
Revenue: $2.13M
Gross Profit: $2.11M (99.20 %)
EPS: $-0.900

Aeterna Zentaris Inc

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators